INACTIVATION OF SELECTED NIAID PROGRAM ANNOUNCEMENTS

Release Date:  October 16, 1998

P.T.

National Institute of Allergy and Infectious Diseases

The National Institute of Allergy and Infectious Diseases (NIAID) is inactivating
its sponsorship of two Program Announcements (PAs).  NIAID will not give special
consideration for funding to applications in response these PAs received after
February 1, 1999.

NIAID regularly reviews its portfolio of active program announcements.  When the
objectives of PAs have been attained, NIAID announces inactivation of those PAs.

NIAID supports highly scientifically meritorious applications in all areas of
research within its mission, including the scientific areas delineated in these
PAs.  PA inactivation simply means that special consideration for funding beyond
normal paylines will NO LONGER be given to applications on the research topics
identified in the inactivated PAs.  However, such applications will be accepted,
reviewed, and considered for funding with all other investigator-initiated
applications.

At any time, potential applicants can obtain a current listing of active NIAID
PAs on the NIAID WWW site at URL: http://www.niaid.nih.gov/ncn/pa-table.htm

The PAs being inactivated are:

PA-97-026, Aspergillosis, Ehrlichioses and Drug Resistance, NIH Guide, January
31, 1997

PA-98-039, Modern Vaccines for Mycoses, NIH Guide, March 6, 1998

INQUIRIES

For questions or further information, contact:

Office of the Director
Division of Extramural Activities
National Institute of Allergy and Infectious Diseases
Solar Building, Room 3C20
Bethesda, MD  20892-7610
Telephone:  (301) 496-7291
FAX:  (301) 402-0369
Email:  [email protected]

Return to Volume Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)